Benutzer: Gast  Login
Dokumenttyp:
journal article 
Autor(en):
Lehmann-Horn, Klaus; Penkert, Horst; Grein, Peter; Leppmeier, Ulrich; Teuber-Hanselmann, Sarah; Hemmer, Bernhard; Berthele, Achim 
Titel:
PML during dimethyl fumarate treatment of multiple sclerosis: How does lymphopenia matter? 
Abstract:
Progressive multifocal leukoencephalopathy (PML), which is caused by the John Cunningham virus (JCV), is a rare brain disease that results in persistent neurologic disability or death. In multiple sclerosis (MS), PML is a major concern in patients treated with natalizumab, and treatment duration (more than 2 years), preceding immunosuppression, and JCV antibody serostatus are identified risk factors, which are used for risk stratification, patient monitoring, and counseling. 
Zeitschriftentitel:
Neurology 
Jahr:
2016 
Band / Volume:
87 
Heft / Issue:
Seitenangaben Beitrag:
440-1 
Sprache:
eng 
Print-ISSN:
0028-3878 
TUM Einrichtung:
Neurologische Klinik und Poliklinik